Prevalence of smoking among psychiatric outpatients

Cited by (1,000)

Items 401–500 of 1,000

1. What do you feel? Adolescent drug and alcohol users show altered brain response to pleasant interoceptive stimuli
   Robyn Migliorini, Jennifer Lorraine Stewart, April Chelsea May, Susan Frances Tapert, Martin P. Paulus · 2013 · Drug and Alcohol Dependence
2. Reduced vasodilatory response to methylnicotinate in schizophrenia as assessed by laser Doppler flowmetry
   Brian M. Ross · 2003 · European Neuropsychopharmacology
3. Prevalence of Smoking in Anxiety Disorders Uncomplicated by Comorbid Alcohol or Substance Abuse
   Sandra Baker Morissette, Suzy Bird Gulliver, Markus Wiegel, David Harrison Barlow · 2004 · Journal of Psychopathology and Behavioral Assessment
4. Smoking among Chinese Patients with Schizophrenia
   Siow Ann Chong, Hock Lai Choo · 1996 · Australian & New Zealand Journal of Psychiatry
5. Características clínicas e qualidade de vida de fumantes em um centro de referência de abordagem e tratamento do tabagismo
   Márcia Regina Pizzo de Castro, Tiemi Matsuo, Sandra Odebrecht Vargas Nunes · 2010 · Jornal Brasileiro de Pneumologia
6. A Smoke-Free Psychiatric Unit
   Michael P. Resnick, Eric E. Bosworth · 1989 · Psychiatric Services
7. Absent response to niacin skin patch is specific to schizophrenia and independent of smoking
   Chih‐Min Liu, Shu‐Sen Chang, Shih‐Cheng Liao, Tzung‐Jeng Hwang, Ming‐Hsien Shieh, Shi-Kai Liu, Wei J. Chen, Hai‐Gwo Hwu · 2007 · Psychiatry Research
8. Impact of Tobacco Regulation on Animal Research: New Perspectives and Opportunities
   Eric C. Donny, T. G. Taylor, Mark G. LeSage, M. Levin, Deanne M. Buffalari, D. Joel, Alan F. Sved · 2012 · Nicotine & Tobacco Research
9. The Role of Nicotine in Schizophrenia
   Robert E. Featherstone, Steven J. Siegel · 2015 · International review of neurobiology
10. Treatment issues: towards a stepped-care model
    1993 · Tobacco Control
11. Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats
    Edward D. Levin, Susan K. Slade, Michael Johnson, Ann E. Petro, Kofi Horton, Paul Williams, Amir H. Rezvani, Jed E. Rose · 2008 · European Journal of Pharmacology
12. Is initiation of smoking associated with the prodromal phase of schizophrenia?
    Kaisa Riala, Helinä H Hakko, Matti K. Isohanni, Anneli M. Pouta, Pirkko K. Räsänen · 2005 · Journal of Psychiatry and Neuroscience
13. Managing Negative Symptoms of Schizophrenia: How Far Have We Come?
    Joshua T. Kantrowitz · 2017 · CNS Drugs
14. Gender and the use of neuroleptics in schizophrenia
    Raimo K. R. Salokangas · 2003 · Schizophrenia Research
15. Concomitant clozapine reduces smoking in patients treated with risperidone
    Ric M. Procyshyn, Gordon Tse, Osric Sin, Sean P. Flynn · 2002 · European Neuropsychopharmacology
16. The expanding indications for clozapine.
    Carl R. Young, James G. Longhurst, Jr. Bowers Malcolm B., Carolyn M. Mazure · 1997 · Experimental and Clinical Psychopharmacology
17. Brief Communication: Tobacco Addiction as a Marker of Age at Onset of Schizophrenia
    Reuven Sandyk, Stanley R. Kay · 1991 · International Journal of Neuroscience
18. Nicotine and clozapine effects on attentional performance impaired by the NMDA antagonist dizocilpine in female rats
    Amir H. Rezvani, Ehsan Kholdebarin, Elizabeth A. Dawson, Edward D. Levin · 2007 · The International Journal of Neuropsychopharmacology
19. Psychological and behavioral traits in smokers and their relationship with nicotine dependence level.
    Mehrnaz Rezvanfard, Hamed Ekhtiari, Azarakhsh Mokri, Gholamreza Esmaeeli Djavid, Hossein Kaviani · 2010 · PubMed
20. The role of amine oxidases in xenobiotic metabolism
    Bin Gong, Paul J Boor · 2006 · Expert Opinion on Drug Metabolism & Toxicology
21. Smoking and tardive dyskinesia: lack of involvement of the CYP1A2 gene
    Siow‐Ann Chong, Ene‐Choo Tan, Chay Hoon Tan, Mythily · 2003 · Journal of Psychiatry and Neuroscience
22. Predictors of smoking behavior of first year university students: questionnaire survey.
    Esra Saatçı, Serpil İnan, Nafiz Bozdemir, Ersin Akpınar, Güney Ergün · 2004 · PubMed
23. Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats
    Paul A. Fredrickson, Mona Boules, Sally Yerbury, Elliott Richelson · 2002 · European Journal of Pharmacology
24. Comorbidity, Smoking Behavior and Treatment Outcome
    Nancy J. Keuthen, RAYMOND S. NIAURA, Belinda Borrelli, Michael G. Goldstein, Judith D. DePue, Chris Murphy, David R. Gastfriend, Stewart R. Reiter, David B. Abrams · 2000 · Psychotherapy and Psychosomatics
25. Medical Disorders in the Schizophrenic Patient
    Victor Vieweg, James L. Levenson, Anand K. Pandurangi, Joel J. Silverman · 1995 · The International Journal of Psychiatry in Medicine
26. DEPRESSION AND SMOKING: A 5-YEAR PROSPECTIVE STUDY OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER
    Irina A. K. Holma, K. Mikael Holma, Tarja K. Melartin, Mikko A Ketokivi, Erkki Tapio Isometsä · 2013 · Depression and Anxiety
27. Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation
    Darlene H. Brunzell, J. Michael McIntosh, Roger L. Papke · 2014 · Annals of the New York Academy of Sciences
28. Cigarette smoking in outpatients with chronic schizophrenia in Taiwan: Relationships to socio-demographic and clinical characteristics
    Yu‐Chen Kao, Yia‐Ping Liu, Tsung-Hsing Cheng, Ming-Kuen Chou · 2011 · Psychiatry Research
29. Drug instrumentalization
    Christian P. Müller · 2020 · Behavioural Brain Research
30. Timing of Alcohol and Smoking Cessation (TASC)
    Anne Marie Joseph, David B. Nelson, Sean M. Nugent, Mark L. Willenbring · 2003 · Journal of Addictive Diseases
31. A psychometric evaluation of the Smoking Consequences Questionnaire–Adult in smokers with psychiatric conditions
    Todd C. Buckley, Barbara Wolfsdorf Kamholz, Susannah L. Mozley, Suzy Bird Gulliver, Dana R. Holohan, Amy W. Helstrom, Kate Walsh, Sandra Baker Morissette, Jon D. Kassel · 2005 · Nicotine & Tobacco Research
32. Personality traits and smoking in patients with obsessive-compulsive disorder
    Susanne Bejerot, Lars von Knorring, Lisa Ekselius · 2000 · European Psychiatry
33. Smoking and psychiatric disorders: a comorbidity survey.
    F. Lopes, I. Nascimento, W. Zin, A. M. Valença, M. A. Mezzasalma, I. Figueira, A. Nardi · 2002 · Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
34. Nicotine: abused substance and therapeutic agent.
    Jacques Le Houezec · 1998 · PubMed Central
35. From Chlorpromazine to Clozapine—Antipsychotic Adverse Effects and the Clinician's Dilemma
    Sabina Abidi, Sreenivasa Bhaskara · 2003 · The Canadian Journal of Psychiatry
36. Cigarette smoking among patients with mental retardation and mental illness
    Norman Hymowitz, Fredric Jaffe, Anil Kumar Gupta, Martin Feuerman · 1997 · Psychiatric Services
37. Schizophrenia and tobacco smoking in a Spanish psychiatric hospital
    Adrián LLerena, Alfredo de la Rubia, Eva Peñas‐Lledó, Francisco J. Díaz, José de León · 2003 · Schizophrenia Research
38. Transdermal nicotine and smoking behavior in psychiatric patients
    N Hartman, Gregory B. Leong, Shirley M. Glynn, JEFFREY N. WILKINS, Murray E. Jarvik · 1991 · American Journal of Psychiatry
39. Genetics of schizophrenia and smoking: an approach to studying their comorbidity based on epidemiological findings
    José de León, Francisco J. Díaz · 2011 · Human Genetics
40. Pharmacological challenge reveals long-term effects of perinatal phencyclidine on delayed spatial alternation in rats
    Jenny L. Wiley, Katriona G. Bühler, Kari L. LaVecchia, Kenneth M. Johnson · 2003 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
41. Smoking habits and plasma lipid peroxide and vitamin E levels in never-treated first-episode patients with schizophrenia
    2000 · The British Journal of Psychiatry
42. A two-year follow-up on the effects of a smoking ban in an inpatient psychiatric service
    J Velasco, Tracy D. Eells, Rachel Lynn Anderson, M Head, Brett M. Ryabik, Ruth Mount, Steven Lippmann · 1996 · Psychiatric Services
43. Effects of response requirement and the availability of an alternative reinforcer on cigarette smoking by schizophrenics
    Jennifer W. Tidey, Stephen T. Higgins, Warren Kurt Bickel, Sandra Steingard · 1999 · Psychopharmacology
44. High-affinity nicotinic acetylcholine receptor expression and trafficking abnormalities in psychiatric illness
    Lewis, Alan S., Picciotto, Marina R. · 2013 · Psychopharmacology
45. An fMRI investigation of delay discounting in patients with schizophrenia
    Kathy Burton Avsar, Rosalyn Eve Weller, James Edward Cox, Meredith Amanda Reid, David Matthew White, Adrienne Carol Lahti · 2013 · Brain and Behavior
46. Levels of S100B are raised in female patients with schizophrenia
    Kara E. O’Connell, Jogin H. Thakore, Kumlesh Kumar Dev · 2013 · BMC Psychiatry
47. Dependência de tabaco e comorbidade psiquiátrica
    André Malbergier, Hercílio Pereira de Oliveira Júnior · 2005 · Archives of Clinical Psychiatry (São Paulo)
48. Treatment of neuroleptic-induced akathisia with nicotine patches
    Michelle Kosche Anfang, Harrison Graham Pope · 1997 · Psychopharmacology
49. Effects of a Smoking Ban on a General Hospital Psychiatric Service
    Wayne R Smith, Brian L. Grant · 1989 · Psychiatric Services
50. Tobacco smoking and nicotine dependence in first episode and established psychosis
    John Lally, Gilda Spaducci, Poonam Gardner-Sood, Zerrin Atakan, Kathryn Greenwood, Marta Di Forti, Khalida Ismail, Kieran C. Murphy, Shubulade M Smith, Ann D. McNeill et al. · 2019 · Asian Journal of Psychiatry
51. Cigarette smoking in Chinese male inpatients with schizophrenia: A cross-sectional analysis
    Y TANG, Tony Peter George, P MAO, Z CAI, Q CHEN · 2005 · Journal of Psychiatric Research
52. Management of physical health in schizophrenia: A stepping stone to treatment success
    Helen L. Millar · 2008 · European Neuropsychopharmacology
53. Smoking among in-patients with drug-related problems in an Australian psychiatric hospital
    Heidi Reichler, Amanda Baker, Terry J. Lewin, Vaughan J. Carr · 2001 · Drug and Alcohol Review
54. Smoking habits in Japanese patients with schizophrenia
    Takeyuki Mori, Tsukasa Sasaki, Akira Iwanami, Tsuyoshi Araki, Kaoru Mizuno, Tadafumi Kato, Nobumasa Kato · 2003 · Psychiatry Research
55. The feasibility of smoking bans on psychiatric units
    Noel E. Taylor, Richard N. Rosenthal, Brent I. Chabus, Stewart Levine, Amy S. Hoffman, Julie Reynolds, Lucy Santos, Ilene F. Wilets, Patricia Friedman · 1993 · General Hospital Psychiatry
56. Pharmacogenetics as a tool in the therapy of schizophrenia
    Bob Wilffert, Rianne J. Zaal, J. R. B. J. Brouwers · 2005 · Pharmacy World & Science
57. Nicotine and clozapine actions on pre-pulse inhibition deficits caused by N-methyl-d-aspartate (NMDA) glutamatergic receptor blockade
    Edward D. Levin, Ann E. Petro, D. Patrick Caldwell · 2005 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
58. Nicotinic Acetylcholine Receptor Dysfunction in Addiction and in Some Neurodegenerative and Neuropsychiatric Diseases
    Ana Sofía Vallés, Francisco José Barrantes · 2023 · Cells
59. Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the “self-medication” hypothesis in schizophrenia
    Douglas Lee Boggs, Toral S. Surti, Irina Esterlis, Brian P. Pittman, Kelly Cosgrove, Richard Andrew Sewell, Mohini Ranganathan, Deepak Cyril D’Souza · 2017 · Schizophrenia Research
60. Acute feasibility and safety of a smoking reduction strategy for smokers with schizophrenia
    Gregory W. Dalack, James H. Meador‐Woodruff · 1999 · Nicotine & Tobacco Research
61. Nicotine and smoker status moderate brain electric and mood activation induced by ketamine, an N-methyl-d-aspartate (NMDA) receptor antagonist
    Verner Knott, Judy F. McIntosh, Anne Millar, Derek J. Fisher, Crystal M. Villeneuve, Vadim Ilivitsky, Edward Horn · 2006 · Pharmacology Biochemistry and Behavior
62. Nicotine improves antisaccade task performance without affecting prosaccades
    Abigail L. Larrison, Kevin A. Briand, Anne B. Sereno · 2004 · Human Psychopharmacology Clinical and Experimental
63. Factors Associated with Readiness to Stop Smoking among Patients in Treatment for Alcohol Use Disorder
    Anne Marie Joseph, Benjamin J. Lexau, Mark Willenbring, Sean M. Nugent, David B. Nelson · 2004 · American Journal on Addictions
64. Nicotinic-antipsychotic drug interactions and cognitive function
    Edward D. Levin, Amir H. Rezvani · 2006 · Birkhäuser Basel eBooks
65. Subjective and physiological responses to smoking cues in smokers with schizophrenia
    Jennifer W. Tidey, Damaris J. Rohsenow, Gary B. Kaplan, Robert M. Swift · 2005 · Nicotine & Tobacco Research
66. Does the degree of smoking effect the severity of tardive dyskinesia? A longitudinal clinical trial
    Alexander Diehl, Iris Reinhard, Andrea Schmitt, Karl F Mann, Wagner F. Gattaz · 2008 · European Psychiatry
67. Clozapine-Resistant Psychosis, Smoking, and Caffeine: Managing the Neglected Effects of Substances That Our Patients Consume Every Day
    Luiz Dratcu, Alistair Grandison, Gavin McKay, Adekunle Bamidele, Vinodini Vasudevan · 2007 · American Journal of Therapeutics
68. Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder
    Mika Hirasawa-Fujita, Michael J. Bly, Vicki L. Ellingrod, Gregory W. Dalack, Edward F. Domino · 2017 · Clinical Schizophrenia & Related Psychoses
69. Nicotine, caffeine, alcohol and schizotypy
    Abigail L. Larrison, Kevin A. Briand, Anne B. Sereno · 1999 · Personality and Individual Differences
70. Short-Term Naturalistic Treatment Outcomes in Cigarette Smokers With Substance Abuse and/or Mental Illness
    Risa B Gershon Grand, Sun Jin Hwang, Juliette M. Han, Tony Peter George, Arthur L. Brody · 2007 · The Journal of Clinical Psychiatry
71. Nicotine and clozapine selectively reverse a PCP-induced deficit of PPI in BALB/cByJ but not NMRI mice: Comparison with risperidone
    Jesper Tobias Andreasen, K.K. Andersen, Elsebet Østergaard Nielsen, L. Mathiasen, N.R. Mirza · 2005 · Behavioural Brain Research
72. Autonomic functioning and cigarette smoking: Heart rate spectral analysis
    FRANCES RUDNICK LEVIN, Howard R. Levin, Craig T. Nagoshi · 1992 · Biological Psychiatry
73. Strain-Specificity in Nicotine Attenuation of Phencyclidine-Induced Disruption of Prepulse Inhibition in Mice: Relevance to Smoking in Schizophrenia Patients
    Cécile Spielewoy, Athina Markou · 2004 · Behavior Genetics
74. Probing the Smoking–Suicide Association: Do Smoking Policy Interventions Affect Suicide Risk?
    Grucza, Richard A., Plunk, Andrew D., Krauss, Melissa J., Cavazos-Rehg, Patricia A., Deak, Joseph, Gebhardt, Kacie, Chaloupka, Frank J., Bierut, Laura J. · 2014 · Nicotine & Tobacco Research
75. Association between tobacco smoking and bipolar affective disorder: clinical, epidemiological, cross-sectional, retrospective study in outpatients
    Anatoly Kreinin, Dmitri Novitski, David L. Rabinowitz, Abraham Weizman, Alexander Grinshpoon · 2011 · Comprehensive Psychiatry
76. Cigarette smoking and white matter microstructure in schizophrenia
    Kathryn Regan Cullen, Stuart R. Wallace, Vincent A. Magnotta, Jeremy H. Bockholt, Stefan Ehrlich, Randy L. Gollub, Dara S. Manoach, Beng‐Choon Ho, Vincent P. Clark, John Lauriello et al. · 2012 · Psychiatry Research Neuroimaging
77. The high-affinity niacin receptor HM74A is decreased in the anterior cingulate cortex of individuals with schizophrenia
    Christine L. Miller, Jeannette R. Dulay · 2008 · Brain Research Bulletin
78. Smoking among suicide attempters
    Stavroula Beratis, Nicoletta P. Lekka, Joanna Gabriel · 1997 · Comprehensive Psychiatry
79. Predictors of Smoking Cessation in a Sample of Italian Smokers
    Antonio Maria Persico · 1992 · International Journal of the Addictions
80. An animal model of nicotinic-acid-induced vasodilation: effect of haloperidol, caffeine and nicotine upon nicotinic acid response
    Sylvie D. Turenne, Mary V. Seeman, Brian M. Ross · 2001 · Schizophrenia Research
81. Psychotic symptoms and smoking in 44 countries
    Ai Koyanagi, Andrew Stickley, Josep María Haro · 2016 · Acta Psychiatrica Scandinavica
82. Neurobiological Links Between Nicotine Addiction and Schizophrenia
    Tony Peter George · 2007 · Journal of Dual Diagnosis
83. Monoamine Oxidase: Radiotracer Development and Human Studies
    Joanna S. Fowler, Jean Logan, Nora D. Volkow, Gene‐Jack Wang, Robert R MacGregor, Yu‐Shin Ding · 2003 · Springer eBooks
84. Smoking and substance abuse in outpatients with schizophrenia: a 2-year follow-up study in Turkey
    Özcan Uzun · 2003 · Drug and Alcohol Dependence
85. Disrupting Nicotine Reinforcement
    Jed E. Rose · 2008 · Annals of the New York Academy of Sciences
86. The stable patient with schizophrenia — From antipsychotic effectiveness to adherence
    Pierre Thomas · 2007 · European Neuropsychopharmacology
87. Chronic nicotine interactions with clozapine and risperidone and attentional function in rats
    Amir H. Rezvani, D. Patrick Caldwell, Edward D. Levin · 2005 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
88. Anxiety, affect, depression and cigarette consumption
    Elisardo Becoña, Fernando L. Vázquez, M J Astillero Fuentes, Marı́a del Carmen Lorenzo · 1998 · Personality and Individual Differences
89. What Is the Clinical Importance of Cigarette Smoking in Schizophrenia?
    Michael R. Lavin, Samuel G. Siris, Susan E. Mason · 1996 · American Journal on Addictions
90. Population Pharmacokinetics of Perphenazine in Schizophrenia Patients From CATIE: Impact of Race and Smoking
    Yuyan Jin, Bruce G. Pollock, Kim C. Coley, Del D. Miller, Stephen R. Marder, Jeff Florian, Lon S. S. Schneider, Jeffrey Lieberman, Margaret A. Kirshner, Robert R. Bies · 2009 · The Journal of Clinical Pharmacology
91. Differing Effects of Antipsychotic Medications on Substance Abuse Treatment Patients with Co‐occurring Psychotic and Substance Abuse Disorders
    Elizabeth B. Stuyt, Terrie A Sajbel, Michael H. Allen · 2006 · American Journal on Addictions
92. Osteoporosis Screening and Treatment in Women with Schizophrenia: A Controlled Study
    Jeffrey R. Bishop, BRUCE K. ALEXANDER, Brian C. Lund, Teresa Bailey Klepser · 2004 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
93. Reversal of Clozapine Effects on Working Memory in Rats with Fimbria–Fornix Lesions
    Nii Addy, Ana Pocivavsek, Edward D. Levin · 2005 · Neuropsychopharmacology
94. Modeling complex genetic and environmental influences on comorbid bipolar disorder with tobacco use disorder
    McEachin, Richard C, Saccone, Nancy L, Saccone, Scott F, Kleyman-Smith, Yelena D, Kar, Tiara, Kare, Rajesh K, Ade, Alex S, Sartor, Maureen A, Cavalcoli, James D, McInnis, Melvin G · 2010 · BMC Medical Genetics
95. Elevated plasma F2-isoprostane levels in schizophrenia
    Ellen Lee, Lisa T. Eyler, Owen M. Wolkowitz, Averria Sirkin Martin, Chase Reuter, HELENA CHMURA KRAEMER, Dilip V. Jeste · 2016 · Schizophrenia Research
96. Ketanserin attenuates nicotine-induced working memory improvement in rats
    Edward D. Levin, Laura Icenogle, Ashkan Farzad · 2005 · Pharmacology Biochemistry and Behavior
97. Nicotine dependence and self-esteem in adolescents with mental disorders
    Marie-Sa Guillon, Marc‐Antoine Crocq, Paul Bailey · 2006 · Addictive Behaviors
98. Substance Use Among Patients with Schizophrenia in a University Hospital
    Yıldız Akvardar, Mevhibe Tümüklü, Berna Binnur Akdede, Halis Ulaş, Arzu Kitiş, Köksal Alptekın · 2004 · Psychiatry and Clinical Psychopharmacology
99. An autoradiographic analysis of [125I]α-bungarotoxin binding in rat brain after chronic nicotine exposure
    Bruce A. Rasmussen, David C. Perry · 2006 · Neuroscience Letters
100. The General Health Status of People with Mental Illness
     Sandra K. Davidson, Fiona K. Judd, Damien Jolley, Barbara M Hocking, Sandra Thompson · 2000 · Australasian Psychiatry